drugset / Trial / NCT00099216
Efficacy and Safety of Rivastigmine Capsules in Patients With Probable Vascular Dementia
RandomizedParallel-groupDouble-blindTreatment
Summary
The goal of this research study is to evaluate the effectiveness, tolerability and safety of rivastigmine capsules in males and females between the ages of 50 and 85 years old with probable vascular dementia.
Timeline
- Start
- 2001-08
- Primary completion
- 2005-11
- Completion
- 2005-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rivastigmine | Small molecule | 3 mg | — |
| Subject | Rivastigmine | Small molecule | 12 mg | — |